(Q99518923)

English

Randomized double blind, placebo controlled phase I trial for anti novel coronavirus pneumonia (COVID-19) recombinant vaccine (Sf9)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

在18周岁及以上健康人群中开展重组新型冠状病毒肺炎(COVID-19)疫苗（Sf9细胞）的单中心、随机、组内双盲、安慰剂对照的Ⅰ期临床试验 (Chinese)

0 references

Randomized double blind, placebo controlled phase I trial for anti novel coronavirus pneumonia (COVID-19) recombinant vaccine (Sf9) among health adults population (English)

0 references

country

People's Republic of China

0 references

start time

28 August 2020

0 references

end time

28 August 2021

0 references

number of participants

168

0 references

clinical trial phase

phase I clinical trial

0 references

exact match

http://www.chictr.org.cn/hvshowproject.aspx?id=51719

0 references

(Q99518923)

Randomized double blind, placebo controlled phase I trial for anti novel coronavirus pneumonia (COVID-19) recombinant vaccine (Sf9)

Statements

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)